Stuki, I'm relieved to see that's all it is. From the limited information of your initial post, I was worried it could have been something much worse, dealing with how BSX invests in its smaller companies.
Yes it's a little problem for BSX, but nothing more than a little bump in the road. It dsoes go to show you need to watch your cards when dealing with the big players, but BIPH seams to be on top of that game with all their recent patent applications pertaining to stent designs.
"Our houses are such unwieldy property that we are often imprisoned rather than housed in them." - Henry David Thoreau, Walden: Economy, 1854